All AGs Settle with Purdue Pharma over Opioid-Related Claims

Cozen O'Connor
Contact

Cozen O'Connor

  • All 55 AGs from the states and territories have settled with Purdue Pharma, Inc., and its owners, members of the Sackler family, to resolve allegations related to the company’s role in fueling the opioid crisis.
  • According to the New York AG’s complaint, Purdue—along with other opioid manufacturers and distributors—contributed to the opioid epidemic by engaging in false and deceptive marketing about the addictiveness of opioids and by failing to prevent the unlawful diversion of controlled substances, violating numerous state laws.
  • The Sacklers will pay $1.5 billion and Purdue will pay roughly $900 million in the first payment, which is expected in early 2026 pending settlement approval, and subsequent payments will be $500 million after one year, an additional $500 million after two years, and $400 million after three years.
  • We have previously covered 16 AGs’ settlement in principle with Purdue and the Sacklers.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Cozen O'Connor

Written by:

Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide